Stocks and Investing Stocks and Investing
Thu, February 4, 2021
Wed, February 3, 2021

Christopher Raymond Maintained (AMGN) at Buy with Decreased Target to $260 on, Feb 3rd, 2021


Published on 2024-10-27 15:29:53 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "Amgen Inc." (AMGN) at Buy with Decreased Target from $280 to $260 on, Feb 3rd, 2021.

Christopher has made no other calls on AMGN in the last 4 months.



There are 8 other peers that have a rating on AMGN. Out of the 8 peers that are also analyzing AMGN, 4 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $215 on, Monday, November 2nd, 2020
  • Colin Bristow of "UBS" Initiated at Hold and Held Target at $232 on, Wednesday, October 28th, 2020
  • Robyn Karnauskas of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $251 on, Monday, October 12th, 2020
  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, October 9th, 2020


These are the ratings of the 4 analyists that currently disagree with Christopher


  • Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $265 on, Thursday, October 29th, 2020
  • Ian Somaiya of "BMO Capital" Maintained at Buy with Decreased Target to $304 on, Thursday, October 29th, 2020
  • Dane Leone of "Raymond James" Upgraded from Hold to Buy and Held Target at $255 on, Monday, October 26th, 2020
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $280 on, Tuesday, October 6th, 2020
Contributing Sources